type here...

CATEGORIES

Coronavirus

LATEST

1...333435Page 35 of 35

TRENDING

EDITORS CHOICE

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

A Closer Look into the Treatments Trump Received for COVID-19

Dr. Hesham A. Hassaballa -
The treatments Donald Trump received can hardly be characterized as “cures,” and here is the data behind each one

Was Covid Testing Used to Harvest Your DNA?

Robert Turner, Founding Editor -
During the pandemic, almost every American was subjected to a PCR test, sometimes on multiple occasions. Where are your data now?

Identifying SARS-CoV-2 Virions Resistant to Monoclonal Antibody Treatment

Julian Willett, MD -
Monoclonal antibodies were first used in humans in the 1980s². They have gradually become more prevalent with Regeneron, producing and selling this treatment for those with severe COVID-19

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories